About 23,300,000 results
Open links in new tab
AbbVie Takes $3.5B Impairment Charge for Failed Schizophrenia ...
Phase 2 schizophrenia fails will cost AbbVie about $3.5B
AbbVie to Post $3.5 Billion Impairment Charge on Failed ...
Abbvie to record $3.5 bln charge related to schizophrenia drug
AbbVie to Record $3.5 Billion Charge on Failed Cerevel Drug (1)
AbbVie News Center - News
AbbVie Tumbles After New Schizophrenia Drug Fails Two Trials